Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________ FORM 10-K ________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _________ Commission File Number: 001-33958 SELLAS Life Sciences G ...

ZELLAS CELLAS | --- | --- | --- | --- | --- | --- | --- | |----------------|------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | Company Overview | | | | | | | NASDAQ: SLS | | | | | | | | | | | | | | | | September 2022 | | | | | | | | | | | | | | | Forward Looking Statements This presentation contains forward-looking statements. Such forward-looking statements can be identified by the use of the words "expect," "believe," "will," "anticipate," "esti ...

| --- | --- | --- | --- | --- | --- | --- | |-----------------------|------------------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | Company Overview | | | | | | | NASDAQ: SLS June 2022 | | | | | | | | | | | | | | | | | | | | | | | ZELLAS CELLAS Forward Looking Statements This presentation contains forward-looking statements. Such forward-looking statements can be identified by the use of the words "expect," "believe," "will," "anticipate," "estimate," "plan," ...

| --- | --- | --- | --- | --- | --- | |-------|-------|-------|-------|-------|-------| | | | | | | | | | | | | | | ΣΕΓΓΑΣ HID LIFE SCIENCES GROUP Forward Looking Statements This presentation contains forward-looking statements. Such forward-looking statements can be identified by the use of the words "expect," "believe," "will," "anticipate," "plan," "plan," "project" and other words of similar import. The forward-looking statements in this presentation include, but are not limited to, statements related t ...

| --- | --- | --- | --- | --- | --- | --- | |--------------|-------|------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | Company Overview | | | | | | NASDAQ: SLS | | | | | | | | January 2020 | | | | | | | | | | | | | | | | | | | | | | | ZELLAS FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements. Such forward-looking statements can be identified by the use of the words "expect," "believe," "will," "anticipate," "estimate," "pla ...

SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) 12th Annual LD Micro Main Event Conference Call December 11, 2019 12:00 PM ET Company Participants Angelos Stergiou - President and Chief Executive Officer Conference Call Participants Angelos Stergiou Good morning, everyone, and great pleasure being here to provide a corporate presentation of SELLAS Life Sciences. As you know, we will be providing forward-looking statements today. So please familiarize yourselves with our recent filings on the website as it rel ...

| --- | --- | --- | --- | --- | --- | --- | |---------------|-------|------------------|-------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | Company Overview | | | | | | NASDAQ: SLS | | | | | | | | February 2019 | | | | | | | | | | | | | | | | | | | | | | | ZELLAS FORWARD LOOKING STATEMENTS This presentation contains forward-looking statements. You can identify such forward-looking statements by the use of the words "expect," "believe," "will," "anticipate," "estimate," "pl ...